These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 22761453)
1. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Mancia G; Facchetti R; Parati G; Zanchetti A Circulation; 2012 Jul; 126(5):569-78. PubMed ID: 22761453 [TBL] [Abstract][Full Text] [Related]
2. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid JL; Rodicio J; Safar M; Eckes L; Rizzini P; Circulation; 2002 Nov; 106(19):2422-7. PubMed ID: 12417537 [TBL] [Abstract][Full Text] [Related]
3. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. Mancia G; Facchetti R; Parati G; Zanchetti A J Hypertens; 2012 Jun; 30(6):1241-51. PubMed ID: 22499291 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness. Zanchetti A; Hennig M; Baurecht H; Tang R; Cuspidi C; Carugo S; Mancia G J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668 [TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid J; Rodicio J; Safar M; Eckes L; Ravinetto R J Hypertens; 1998 Jul; 16(7):949-61. PubMed ID: 9794735 [TBL] [Abstract][Full Text] [Related]
6. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis. Mancia G; Parati G; Bilo G; Maronati A; Omboni S; Baurecht H; Hennig M; Zanchetti A J Hypertens; 2007 May; 25(5):1087-94. PubMed ID: 17414674 [TBL] [Abstract][Full Text] [Related]
7. Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA). Giannattasio C; Failla M; Hennig M; Hollweck R; Laurent S; Mallion JM; Reid J; Safar M; Bond G; Zanchetti A; Mancia G J Hypertens; 2005 Mar; 23(3):557-62. PubMed ID: 15716697 [TBL] [Abstract][Full Text] [Related]
8. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). Mancia G; Parati G; Hennig M; Flatau B; Omboni S; Glavina F; Costa B; Scherz R; Bond G; Zanchetti A; J Hypertens; 2001 Nov; 19(11):1981-9. PubMed ID: 11677363 [TBL] [Abstract][Full Text] [Related]
9. Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA). Zanchetti A; Bond MG; Hennig M; Tang R; Hollweck R; Mancia G; Eckes L; Micheli D; J Hypertens; 2004 Jun; 22(6):1201-12. PubMed ID: 15167456 [TBL] [Abstract][Full Text] [Related]
10. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy. Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Matayoshi T; Takiuchi S; Kamide K; Nakamura S; Horio T Clin Exp Hypertens; 2013; 35(4):279-84. PubMed ID: 23530977 [TBL] [Abstract][Full Text] [Related]
11. [The preliminary clinical evidence from the ELSA study. The European Lacidipine Study on Atherosclerosis]. Leonetti G Ann Ital Med Int; 1995 Oct; 10 Suppl():74S-77S. PubMed ID: 8562272 [TBL] [Abstract][Full Text] [Related]
12. Association Between Short-Term Systolic Blood Pressure Variability and Carotid Intima-Media Thickness in ELSA-Brasil Baseline. Ribeiro AH; Lotufo PA; Fujita A; Goulart AC; Chor D; Mill JG; Bensenor IM; Santos IS Am J Hypertens; 2017 Oct; 30(10):954-960. PubMed ID: 28475663 [TBL] [Abstract][Full Text] [Related]
13. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Zanchetti A; Hennig M; Hollweck R; Bond G; Tang R; Cuspidi C; Parati G; Facchetti R; Mancia G Circulation; 2009 Sep; 120(12):1084-90. PubMed ID: 19738145 [TBL] [Abstract][Full Text] [Related]
14. Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis. Bombelli M; Macchiarulo M; Facchetti R; Maggiolini D; Cuspidi C; Parati G; Mancia G; Grassi G J Hypertens; 2019 Apr; 37(4):844-850. PubMed ID: 30817467 [TBL] [Abstract][Full Text] [Related]
15. Visit-to-visit blood pressure variability, average BP level and carotid arterial stiffness in the elderly: a prospective study. Nagai M; Dote K; Kato M; Sasaki S; Oda N; Kagawa E; Nakano Y; Yamane A; Kubo Y; Higashihara T; Miyauchi S; Harada W; Masuda H J Hum Hypertens; 2017 Apr; 31(4):292-298. PubMed ID: 27762309 [TBL] [Abstract][Full Text] [Related]
16. Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial. Umemoto S; Ogihara T; Matsuzaki M; Rakugi H; Ohashi Y; Saruta T; Hypertens Res; 2016 Jan; 39(1):46-53. PubMed ID: 26490089 [TBL] [Abstract][Full Text] [Related]
17. Potential modification of plaque behavior through the European lacidipine study on atherosclerosis. Bond MG; Mercuri M J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S11-6. PubMed ID: 8852539 [TBL] [Abstract][Full Text] [Related]
18. Relationship of short-term blood pressure variability with carotid intima-media thickness in hypertensive patients. Chen Y; Xiong H; Wu D; Pirbhulal S; Tian X; Zhang R; Lu M; Wu W; Huang W Biomed Eng Online; 2015 Jul; 14():71. PubMed ID: 26204889 [TBL] [Abstract][Full Text] [Related]
19. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Tatasciore A; Renda G; Zimarino M; Soccio M; Bilo G; Parati G; Schillaci G; De Caterina R Hypertension; 2007 Aug; 50(2):325-32. PubMed ID: 17562971 [TBL] [Abstract][Full Text] [Related]
20. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Rothwell PM; Howard SC; Dolan E; O'Brien E; Dobson JE; Dahlöf B; Poulter NR; Sever PS; Lancet Neurol; 2010 May; 9(5):469-80. PubMed ID: 20227347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]